In term of women who have been treated with therapeutic radiation, the Faculty of Radiation Oncology (2010) estimates that there may be at most, 1000 additional women who would be considered at high risk as a result of receiving chest irradiation for Hodgkin’s Lymphoma and therefore potentially eligible for screening with MRI. There would also be additional women who had received radiation to the chest area for conditions such as sarcoma - though this is likely to be a smaller population than those with Hodgkin’s Lymphoma. Table 4: List of resources to be considered in the economic analysis (this may be expanded upon in the subsequent review) Number of Disaggregated unit cost of resource per relevant Provider of Private Setting in Proportion time Safety Total resource MBS govt health Patient which of patients horizon per nets* cost budget insurer resource is receiving patient provided resource receiving resource Resources associated with conventional screening (mammography +/- ultrasound) GP/other outpatient 100 Weighted average costs of a medical consultation Specialist Specialist Out patient 100 Consultation Mammogram Radiologist Outpatient 100 Ultrasound Resources associated with the addition of MRI to conventional screening Weighted average GP/other Outpatient 100 cost of medical consultation Specialist Specialist Outpatient 100 appointment MRI Radiologist Outpatient 100 Mammogram Radiologist Outpatient Ultrasound Radiologist Outpatient Resources associated with follow-up resources prompted by screening Surgical biopsy Specialist Outpatient 31506 $337.60 Anaesthetic costs Specialist Outpatient Fine needle Specialist Outpatient 31533 aspiration biopsy $132.70 Specialist Outpatient 55070 Ultrasound guidance $98.25 Core needle biopsy Specialist Outpatient $132.70 Stereotactic biopsy Specialist Outpatient 31545 $573.10 Specialist Specialist Outpatient appointment Resources associated with treatment Breast Surgery Specialist Inpatient Specialist Inpatient/ Radiotherapy Outpatient Specialist Inpatient/ Chemotherapy Outpatient Specialist Outpatient Hormone therapy MRI compatible needles and disposables may also need to be considered ‐
In term of women who have been treated with therapeutic radiation, the Faculty of Radiation Oncology (2010) estimates that there may be at most, 1000 additional women who would be considered at high risk as a result of receiving chest irradiation for Hodgkin’s Lymphoma and therefore potentially eligible for screening with MRI. There would also be additional women who had received radiation to the chest area for conditions such as sarcoma - though this is likely to be a smaller population than those with Hodgkin’s Lymphoma. Table 4: List of resources to be considered in the economic analysis (this may be expanded upon in the subsequent review) Provider of resource Setting in which resource is provided Proportion of patients receiving resource Number of of resource per relevant time horizon per patient receiving resource Disaggregated unit cost MBS Safety nets* govt budget Private health insurer Patient Total cost Resources associated with conventional screening (mammography +/- ultrasound) Weighted average costs of a medical consultation GP/other outpatient 100 Specialist Consultation Specialist Out patient 100 Mammogram Radiologist Outpatient 100 Ultrasound Resources associated with the addition of MRI to conventional screening Weighted average cost of medical consultation GP/other Outpatient 100 Specialist appointment Specialist Outpatient 100 MRI Radiologist Outpatient 100 Mammogram Radiologist Outpatient Ultrasound Radiologist Outpatient Resources associated with follow-up resources prompted by screening Surgical biopsy Specialist Outpatient 31506 $337.60 Anaesthetic costs Specialist Outpatient Fine needle aspiration biopsy Specialist Outpatient 31533 $132.70 Ultrasound guidance Specialist Outpatient 55070 $98.25 Core needle biopsy Specialist Outpatient $132.70 Stereotactic biopsy Specialist Outpatient 31545 $573.10 Specialist appointment Specialist Outpatient Resources associated with treatment Breast Surgery Specialist Inpatient Radiotherapy Specialist Inpatient/ Outpatient Chemotherapy Specialist Inpatient/ Outpatient Hormone therapy Specialist Outpatient ‐ MRI compatible needles and disposables may also need to be considered
1098.1-FINAL-DAP.docx